<?xml version="1.0" encoding="UTF-8"?>
<p id="Par70">Gupta et al. performed a survey among rheumatologists in India to assess the attitudes of physicians while initiating anti-rheumatic therapies during COVID-19 pandemic [
 <xref ref-type="bibr" rid="CR158">158</xref>]. They observed that almost 60% of the respondents preferred an earlier taper of glucocorticoids during inactive disease. 66.5% of the respondents were more inclined to initiate HQ in patients with borderline indications. And, almost half reduced the usage of biologic drugs.
</p>
